Biotech founders are currently navigating a tough fundraising landscape compared to the flourishing years of 2019-2021, as investor focus has…
Browsing: Recovery
Vera Therapeutics (VERA) has recently gained attention with its stock price rising approximately 10% in a day and a similar…
The biotech sector is experiencing a resurgence, with forecasts indicating a thawing from its “nuclear financial winter” by 2026, leading…
The biopharma job market shows early signs of recovery, but experts have differing opinions on when a significant turnaround will…
Inovio Pharmaceuticals has recently attracted attention from small-cap biotech traders, indicating it could be a speculative rebound candidate. However, the…
The life sciences sector in Greater Philadelphia is currently facing challenges, marked by an 18.4% vacancy rate and significant cuts…
Life sciences stocks are experiencing a rebound, which is promising for companies like Danaher. Following Agilent Technologies’ recovery—evidenced by a…
Venture capital investment in healthcare technology startups surged in 2025, with funding exceeding the total from last year, according to…
In the third quarter, Florida-based wealth advisory J. L. Bainbridge & Co. sold 119,376 shares of Biogen (BIIB) for approximately…
Florida-based J.L. Bainbridge & Co. sold 119,376 shares of Biogen for approximately $16.1 million in the third quarter, significantly reducing…